Depo-Provera Settlement Amounts 2026: MDL 3140 Payout Tiers & Case Value
Depo-Provera settlement amounts in 2026 may vary widely based on meningioma diagnosis severity, duration of Depo-Provera use, tumor treatment, neurological impact, documented economic loss, and the strength of medical and pharmacy records.
Key Facts About Depo-Provera Settlement Amounts in 2026
Depo-Provera Settlement Amounts by Injury Type
The table below gives projected Depo-Provera settlement amounts by claim category. These estimates are based on comparable pharmaceutical mass tort valuation patterns, meningioma treatment burden, disability impact, economic loss, and likely settlement matrix factors. No settlement amount is guaranteed.
| Claim Category | Estimated Settlement Range | Common Case-Value Factors |
|---|---|---|
| Lower-Tier Meningioma | $100,000 – $300,000 | Smaller tumor, watch-and-wait monitoring, limited symptoms, shorter Depo-Provera use history, or lower economic damages. |
| Moderate Meningioma | $300,000 – $750,000 | Surgery, extended recovery, partial neurological symptoms, documented treatment, clear injection history, or meaningful wage loss. |
| Severe or Recurrent Meningioma | $750,000 – $1,500,000+ | Recurring tumor, radiation, multiple procedures, permanent neurological impairment, cognitive harm, disability, or extensive economic loss. |
| Wrongful Death / Catastrophic Loss | $1,000,000+ | Death or severe permanent disability tied to tumor complications, economic dependency, family loss, and strong causation evidence. |
Latest Depo-Provera MDL 3140 Updates
Depo-Provera product liability cases are centralized in MDL No. 3140 in the Northern District of Florida. The official court page states that transferred actions share allegations that Depo-Provera or generic equivalents can cause users to develop one or more meningiomas.
Daubert Hearings
The MDL court’s order page lists expert-related hearings for June 24–26, 2026. Expert rulings can affect settlement pressure and valuation.
FDA Label Context
The revised 2025 Depo-Provera labeling includes meningioma-related risk language, which plaintiffs may cite in failure-to-warn arguments.
Bellwether Pressure
Bellwether trial scheduling and pretrial rulings often shape settlement negotiations in pharmaceutical MDL litigation.
Depo-Provera Settlement Payout Tiers Explained
- Aggressive, recurrent, or surgically complex meningioma
- Surgery, radiation, or multiple procedures
- Permanent neurological or cognitive impairment
- Strong long-term Depo-Provera exposure records
- Major wage loss, disability, or future-care damages
- Single surgery or significant treatment
- Partial neurological symptoms or extended recovery
- Documented injection history and diagnosis timing
- Meaningful medical expenses or lost wages
- Clear but less severe long-term impact
- Watch-and-wait diagnosis or lower symptom burden
- Smaller tumor or limited treatment history
- Shorter use duration or weaker documentation
- Limited economic loss
- Some competing risk or causation disputes
Who May Qualify for a Depo-Provera Settlement?
You may qualify for a Depo-Provera claim if you used injectable medroxyprogesterone acetate and were later diagnosed with an intracranial meningioma. Eligibility depends on product history, diagnosis timing, state filing deadlines, and whether the claim can be supported with medical and pharmacy evidence.
Common Eligibility Factors
- Received Depo-Provera or generic medroxyprogesterone acetate injections
- Used injections for one year or longer
- Diagnosed with intracranial meningioma after or during use
- Have medical records, imaging, pathology, or neurology notes
- Have not already fully released the claim in a prior settlement
Claims That May Be Stronger
- Longer duration of injections
- Surgery, radiation, recurrence, or permanent symptoms
- Consistent pharmacy, OB/GYN, clinic, or insurance records
- Economic loss, disability, or future-care needs
- Diagnosis within a legally timely filing window
Factors That Increase Depo-Provera Settlement Amounts
The strongest claims usually have clear Depo-Provera exposure, strong medical documentation, and significant treatment or life impact. A claimant may receive a higher projected tier when the evidence reduces disputes over exposure, diagnosis, causation, and damages.
Duration of Use
Long-term or repeated Depo-Provera injections may strengthen exposure evidence.
Tumor Severity
Larger, symptomatic, recurrent, or surgically complex meningiomas generally carry higher projected value.
Treatment Burden
Surgery, radiation, hospitalization, rehabilitation, and future care can increase documented damages.
Economic Loss
Lost income, reduced earning capacity, disability, and out-of-pocket costs affect settlement value.
Documentation
Pharmacy records, insurance records, injection logs, imaging, and pathology reports help prove the claim.
Legal Timing
Filing before the statute of limitations expires is critical to preserving settlement rights.
Evidence Needed to Support Higher Depo-Provera Settlement Amounts
Evidence can determine whether a claim is placed in a higher or lower settlement tier. Better records may increase projected Depo-Provera settlement amounts because they reduce disputes over exposure, diagnosis, and damages.
- Injection records: OB/GYN records, clinic records, pharmacy records, insurance claims, or prescription history.
- Diagnosis records: MRI or CT imaging, neurology notes, pathology reports, and meningioma staging or grading information.
- Treatment records: Surgery reports, radiation notes, hospitalization records, medications, rehab, and follow-up care.
- Damages records: Lost income, disability records, medical bills, travel costs, and future-care documentation.
- Timeline proof: A written exposure and diagnosis timeline showing when injections occurred and when symptoms or diagnosis appeared.
How to File a Depo-Provera Claim
1. Gather Records
Collect Depo-Provera injection records, medical imaging, diagnosis records, and treatment documentation.
2. Estimate Value
Use the Depo-Provera settlement calculator below to organize diagnosis, treatment, use duration, and damages factors.
3. Request Review
Submit a free case review so a specialist can compare your facts against eligibility and settlement-value factors.
Depo-Provera Settlement Calculator
Estimate your potential Depo-Provera settlement value by comparing your meningioma diagnosis, treatment history, injection duration, and damages against projected payout tiers.
Sources and Reputable Linkouts
This Depo-Provera settlement amounts guide uses reputable public sources for medical research, FDA labeling, MDL procedure, and litigation context. External source links are standard editorial citations and do not include nofollow attributes.
MDL 3140 Court Page
N.D. Florida — Depo-Provera Products Liability Litigation
Official court page for MDL No. 3140 and transferred-case allegations.
MDL Orders and Hearing Dates
N.D. Florida — MDL 3140 Orders by Date
Official order list and scheduling information for the Depo-Provera MDL.
FDA Labeling
FDA — Depo-Provera CI Prescribing Information
Federal label information including revised meningioma-related language.
BMJ Research
BMJ — Progestogens and Intracranial Meningioma Risk
Peer-reviewed research discussing medroxyprogesterone acetate and meningioma risk.
JAMA Neurology Research
JAMA Neurology — Depot Medroxyprogesterone Acetate and Meningioma Risk
Large U.S. study on depot medroxyprogesterone acetate exposure and meningioma diagnosis risk.
PubMed Index
PubMed — Medroxyprogesterone and Meningioma Research
Research index for medical literature related to medroxyprogesterone and meningioma.
Frequently Asked Questions About Depo-Provera Settlement Amounts
How much are Depo-Provera settlement amounts in 2026?
Projected Depo-Provera settlement amounts may range from about $100,000 to $300,000 for lower-tier claims, $300,000 to $750,000 for moderate cases, and $750,000 to $1.5 million or more for severe meningioma claims.
Who qualifies for a Depo-Provera settlement?
Potential claimants typically used Depo-Provera or generic medroxyprogesterone acetate injections and were later diagnosed with an intracranial meningioma. Medical, pharmacy, and diagnosis records are important.
What factors increase Depo-Provera lawsuit payout value?
Severe meningioma, surgery, radiation, recurrence, permanent neurological symptoms, long-term injection history, strong documentation, lost income, and disability can increase projected settlement value.
Is there a free Depo-Provera settlement calculator?
Yes. TortAdvisor’s Depo-Provera settlement calculator can help organize diagnosis, treatment, exposure, and damages facts into an educational value estimate.
Has Pfizer settled Depo-Provera lawsuits?
No global settlement has been announced for MDL 3140. Settlement timing depends on pretrial rulings, expert evidence, bellwether trials, and negotiation pressure.
Do I need an attorney for a Depo-Provera settlement claim?
Attorney review is strongly recommended because pharmaceutical MDL cases involve medical causation, expert evidence, filing deadlines, records collection, and settlement matrix valuation.
Use the Depo-Provera Settlement Calculator
Estimate your potential Depo-Provera settlement range based on meningioma diagnosis severity, length of use, treatment history, permanent symptoms, medical evidence, and economic damages.
